PEDIATRICS Vol. 59 No. 4 April 1977, pp. 643
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, B.
Right arrow Articles by Groth, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, B.
Right arrow Articles by Groth, P.

Scabies: Transcutaneous Poisoning During Treatment

Beulah Lee Pharm.D. and Paul Groth M.S., B.S.Pharm.

The FDA Drug Bulletin (6:28, 1976) alerted physicians and other health professionals to the possibility of adverse central nervous system (CNS) side effects, particularly in children, that may occur from high doses of the commonly employed scabicides. The American Academy of Pediatrics has requested its members to report adverse reactions from scabicides to the AAP, which, in turn, will keep the FDA informed.

Following the FDA Drug Bulletin alert and the announcement by the AAP, the FDA's Division of Drug Experience received the following clinical reports of suspected CNS toxicity to gamma benzene hexachloride (GBH, Kwell, Gamene, lindane).




This article has been cited by other articles:


Home page
 PsychosomaticsHome page
R. C.W. Hall and R. C.W. Hall
Long-Term Psychological and Neurological Complications of Lindane Poisoning
Psychosomatics, December 1, 1999; 40(6): 513 - 517.
[Full Text]